✨ Your Portfolio is fetched and updated from zerodha.

Pharma Sector

Index
  • 1m
  • 6m
  • ytd
  • 1y
  • 3y
  • 5y
  • max
Constituents (247 Companies)
Company Name
PE
Market Cap (Cr.)
M.Cap (Cr.)
39.47
4,30,837
64.21
1,59,175
63.55
1,44,394
19.22
1,06,999
22.98
1,06,749
22.08
1,00,379
18.27
90,219
47.34
84,227
21.88
76,303
26.94
63,890
57.51
61,252
99.29
59,990
36.47
55,578
64.61
54,488
44.16
40,178
37.49
38,272
84.79
38,264
34.74
35,250
43.83
33,039
36.04
31,351
33.25
28,165
66.16
22,027
25.13
21,447
72.59
20,831
98.89
19,865
878
19,321
-
19,075
43.07
18,593
11.25
17,522
828
16,645
86.46
15,488
28.31
15,444
31.08
13,447
21.05
13,240
93.92
12,619
35.85
12,465
22.12
12,029
19.29
11,837
56.47
11,389
24.79
10,882
33.95
10,609
47.98
9,931
64.67
9,664
39.22
9,416
16.93
8,659
106
8,180
27.39
8,038
23.49
7,474
20.48
7,378
17.79
7,351
49.36
6,845
45.62
6,844
20.28
5,954
25.84
5,522
24.17
5,238
25.54
4,731
-
3,919
29.00
3,840
-
3,673
40.41
3,620
-
3,428
33.44
3,397
15.14
3,068
14.89
3,017
19.51
2,970
56.43
2,823
57.36
2,741
135
2,553
21.25
2,318
19.74
2,287
18.87
2,242
-
2,134
6.78
1,998
19.91
1,980
-
1,957
6.09
1,939
-
1,922
24.20
1,616
-
1,603
25.95
1,477
25.53
1,443
47.95
1,398
37.35
1,311
30.03
1,228
4.82
1,198
13.36
1,173
15.22
1,162
45.73
1,153
27.40
1,122
17.92
1,077
25.18
1,068
14.93
1,029
19.35
1,012
11.48
1,007
28.36
927
26.93
890
38.32
888
44.08
884
18.75
806
16.83
704
-
648
-
642
35.25
637
30.05
617
36.59
584
33.13
548
37.16
497
18.47
481
13.76
446
21.73
430
32.57
394
19.72
391
36.16
380
43.70
351
36.09
347
49.10
343
34.26
323
26.29
309
-
287
23.88
277
27.77
268
54.44
267
24.26
258
26.55
255
25.45
250
78.84
244
38.76
226
65.33
216
-
214
25.73
211
19.80
206
11.05
195
17.45
193
-
190
13.31
181
-
173
20.76
172
660
171
57.52
170
-
166
24.85
165
30.84
165
46.11
158
12.21
153
55.00
144
-
144
31.20
141
27.94
134
10.77
133
9.25
129
15.83
127
5.90
127
26.67
122
12.48
120
4.49
109
9.31
109
434
109
-
107
15.89
107
12.91
105
26.25
98
20.39
98
-
94
10.87
93
163
93
18.57
88
23.50
87
70.74
86
9.59
84
10.84
74
12.18
74
25.70
72
6.47
69
-
68
-
67
89.68
66
9.12
65
14.22
61
13.85
60
-
60
-
58
11.79
58
12.11
58
7.49
54
11.30
51
2.88
51
11.12
47
210
47
13.74
46
-
46
16.46
46
-
45
-
45
110
44
18.38
43
-
42
95.31
42
50.35
40
51.95
39
-
38
35.51
37
14.81
37
20.77
32
16.37
32
34.48
30
350
30
-
28
-
27
-
26
6.32
26
5.95
25
11.68
25
-
25
7.14
24
26.34
23
10.69
22
-
21
23.27
21
7.96
18
-
16
24.38
15
32.83
15
51.21
15
12.96
13
-
13
-
12
-
12
36.15
12
22.26
11
75.03
10
8.95
9
-
9
717
9
53.12
8
89.76
7
824
7
-
7
-
6
-
6
-
5
-
5
41.83
4
-
3
50.52
3
-
2
-
1
-
-
Showing 5 247 of 247 Show More
Market Share

    Select a Metric
    • Gastrointestinal (Nurokind-LC) - Market Share (%)
    • Fermentation Based API Products - Market Share (%)
    • Depression (Placida) - Market Share (%)
    • Birth Control (Unwanted-72) - Market Share (%)
    • Anti Fungal Antibiotics (Terbinaforce) - Market Share (%)
    • Anti-Hypertensives (Amolkind-AT) Market Share (%)
    • Gastro-Intestinal - Market Share (%)
    • Vaccines - Market Share (%)
    • Sex Stimulants - Market Share (%)
    • Pharmaceutical Sector - Market Share (%)
    • Cardiovascular - Market Share (%)
    • Vitamin & Dietary Supplements - Market Share (%)
    • Anti - Diabetes - Market Share (%)
    • Anti-Infectives - Market Share (%)
    Operational Metrics

    Select a Metric
    • Pharma spend as a % of GDP - India (%)
    • Pharma spend as a % of GDP - Korea (%)
    • Pharma spend as a % of GDP - USA (%)
    • Domestic Pharma - Monthly Sales (Crs)
    • Domestic Pharma Price Growth (%)
    • Domestic Pharma Volume Growth (%)
    • Total ANDA's Approved by USFDA

      Select a Metric
      • Fermentation Capacity (KL)
      • No Of Pharmacies (.)
      • Number of ANDA's Approved By USFDA (.)
      • Number of ANDA's Filed in USA (.)
      • Manufacturing Capacity - Metformin (MTPA)
      • No of Pharmacy Outlets - Kolkata (.)
      • Quarterly Sales Volume - Injectables (Nos)
      • Quarterly Sales Volume - Nutraceuticals (Nos)
      • Quarterly Sales Volume - Orals (Nos)
      • Realization / Tonne - Piperazine (Rs/MT)
      • Manufacturing Capacity - Pyridin-3-One (MTPA)
      • Realization / Tonne - Pyridin-3-One (Rs/MT)
      • Domestic Sales Growth - YoY (%)
      • Number of ANDA's Approved (.)
      • Number of ANDA's Filed in Europe
      • Number of ANDA's Approved in Europe
      • Canada DMF fillings (.)
      • US DMF Filings (.)
      • Australia DMF fillings (.)
      • US DMF Approval (.)
      • Europe DMF Filings (.)
      • DMF Filingsby API (.)
      • Total reactor capacity (kL)
      • Global DMFs filed (.)
      • APIs Production Capacity (MTPA)
      • Japan DMF Filings (.)
      • Realization - Tetralone (Rs/Tonne)
      • Manufacturing Capacity - Omeprazole (MTPA)
      • Capacity Utilization - Esomeprazole (%)
      • Realization - Pantaprazole Sodium (Rs/Tonne)
      • Capacity Utilization - Benzimidazole (%)
      • Capacity Utilization - Omeprazole (%)
      • Manufacturing Capacity - Benzimidazole (MTPA)
      • Realization - Chloro Compound (Rs/Tonne)
      • Manufacturing Capacity - Pantaprazole (MTPA)
      • Realization - Op. Sulphide (Rs/Tonne)
      • Realization - Esomeprazole Magnesium (Rs/Tonne)
      • Capacity Utilization - Chloro Compound (%)
      • Capacity Utilization - Pantaprazole (%)
      • Realization - Benzimidazole (Rs/Tonne)
      • Realization - Omeprazole Powder (Rs/Tonne)
      • Manufacturing Capacity - Esomeprazole (MTPA)
      • Manufacturing Capacity - Chloro Compound (MTPA)
      • Realization - Ammonium Sulphate (Rs/Tonne)
      • Manufacturing Capacity - Ibuprofen (MTPA)
      • Capacity Utilization - Pharmaceuticals (%)
      • Number of ANDA's Filed in Canada
      • Number of ANDA's Approved by Canada
      • Number of ANDA's Filed in Australia
      • Number of ANDA's Approved by Australia
      • Number of ANDA's Filed in South Africa
      • Number of ANDA's Approved by South Africa
      • Number of ANDA's Filed in Latam
      • Number of ANDA's Approved by Latam
      • Manufacturing Capacity - Piperazine (MTPA)
      • Manufacturing Capacity - Paracetamol (MTPA)
      • No of Pharmacy Outlets - Hyderabad (.)
      • No of Pharmacy Outlets - Bangalore (.)
      • No of Pharmacy Outlets - Chennai (.)
      Segments

      Select a Metric
      • Therapeutic wise Break-Up - Domestic Pharma (Crs)
      • Dermatology (Crs)
      • Cardiovascular (Crs)
      • Blood Related (Crs)
      • Antineo Plastic (Crs)
      • Anti-Malarial (Crs)
      • Anti - Infectives (Crs)
      • Vaccines (Crs)
      • Stomatological (Crs)
      • Sex Stimulants (Crs)
      • Respiratory (Crs)
      • Pain (Crs)
      • Others (Crs)
      • Ophthalmology (Crs)
      • Neurological (Crs)
      • Gynecology (Crs)
      • Gastro-Intestinal (Crs)
      • Endocrinology (Crs)
      • Urology (Crs)
      • Vitamin & Dietary Supplements (Crs)
      • Anti - Diabetes (Crs)
      • Indian vs MNC - Domestic Share (Crs)
      • Indian (Crs)
      • MNC (Crs)
      Export Import Data

      • 1y
      • 2y
      • 3y
      • 5y
      • 10y
        Select a Metric
        • Pharmaceutical Products (Kgs)
        Ideas Dashboard
        Results
        Timeline
        Watchlist
        Portfolio
        Alerts
        Stock Screener
        Market
        Raw Material